Latest price-to-book ratio
TScan Therapeutics Price-to-book ratio
Direct answer
TScan Therapeutics's price-to-book ratio is 0.18x.
The verified market snapshot reports 0.18x.
Bullstory displays the reported value and does not estimate missing data.
Market data checked October 26, 2026.
Get free TScan Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Price-to-book ratio
- 0.18x
Explore related company data
View TScan Therapeutics's market capitalizationView TScan Therapeutics's return on equityView TScan Therapeutics's dividend yieldView TScan Therapeutics's 52-week price rangeView TScan Therapeutics's revenue growthView TScan Therapeutics's profit marginView TScan Therapeutics's debt-to-equity ratioView all TScan Therapeutics key metricsReturn to TScan Therapeutics profile